Correlation between soluble FLT1 and clinical features of patients with Hereditary Hemorrhagic Telangiectasia

Correlation between soluble FLT1 and clinical features of patients with Hereditary Hemorrhagic Telangiectasia - Soluble FLT1 in patients with HHT

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON45691

Enrollment

Registered

2017-03-31

Start date

2017-04-01

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hereditary Hemorrhagic Telangiectasia Rendu-Osler-Weber syndrome

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with (I) hereditary hemorrhagic telangiectasia type 2 (ACVRL1 mutation) who have been screened previously by the st antonius hospital, HHT centre of exellence, (II) 18 years or older and (III) mentally competent.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Level of sFLT1 in correlation to symptom severity.	—

Secondary

Measure	Time frame
geen	—

Countries

Netherlands

Outcome results